Fezolamine

CAS No. 80410-36-2

Fezolamine( —— )

Catalog No. M36171 CAS No. 80410-36-2

Fezolamine is a novel orally available non-tricyclic compound with antidepressant activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 170 Get Quote
5MG 247 Get Quote
10MG 371 Get Quote
25MG 601 Get Quote
50MG 854 Get Quote
100MG 1134 Get Quote
500MG 2277 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Fezolamine
  • Note
    Research use only, not for human use.
  • Brief Description
    Fezolamine is a novel orally available non-tricyclic compound with antidepressant activity.
  • Description
    Fezolamine is a novel orally available non-tricyclic compound with antidepressant activity. It is three to two times more selective in blocking synaptosomal uptake of [3H]norepinephrine than uptake of [4H]3-hydroxytryptamine or [3H]dopamine in vitro. It blocked the inhibitory effects of rifampicin and tetraphenyl in classical behavioral tests using monoamine-depleted animals.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Neuroscience
  • Target
    Norepinephrine
  • Recptor
    Norepinephrine
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    80410-36-2
  • Formula Weight
    305.42
  • Molecular Formula
    C20H23N3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CCN(C)C)N1C=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Cianopramine

    Cianopramine (Ro 112465) is a selective 5-hydroxytryptamine uptake inhibitor and a tricyclic antidepressant used in the study of neurological disorders.

  • Diosmin

    Diosmin is a semisynthetic phlebotropic agent and a member of the flavonoid family.

  • Amfepramone hydrochl...

    A appetite depressant considered to produce less central nervous system disturbance than most drugs in this therapeutic category.